Two Sigma Securities’s VolitionRx Ltd VNRX Stock Holding History

Two Sigma Securities’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.19K	Buy	789 +59	+8%	+$282	﹤0.01%	1540
2025 Q4	$3.73K	Buy	+730	New	+$5.54K	﹤0.01%	1356
2025 Q2	–	Sell	-1,074	Closed	-$12.2K	–	2136
2025 Q1	$12.2K	Sell	1,074 -1,372	-56%	-$16.4K	﹤0.01%	1193
2024 Q4	$29.3K	Buy	+2,446	New	+$32.8K	﹤0.01%	1253
2024 Q2	–	Sell	-1,134	Closed	-$17.2K	–	3705
2024 Q1	$17.2K	Buy	1,134 +546	+93%	+$10.7K	﹤0.01%	2688
2023 Q4	$8.43K	Sell	588 -820	-58%	-$12.1K	﹤0.01%	2844
2023 Q3	$19.4K	Buy	1,408 +614	+77%	+$15.2K	﹤0.01%	2576
2023 Q2	$22.1K	Buy	794 +290	+58%	+$9.54K	﹤0.01%	2492
2023 Q1	$19.3K	Sell	504 -160	-24%	-$6.7K	﹤0.01%	2369
2022 Q4	$32.2K	Sell	664 -1,054	-61%	-$40.9K	﹤0.01%	2219
2022 Q3	$47K	Buy	+1,718	New	+$65K	﹤0.01%	2190

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Two Sigma Securities's VNRX Position: Q1 2026 in Review

Two Sigma Securities increased its VolitionRx Ltd (VNRX) stake by 8.1% in Q1 2026, buying an estimated $282 and bringing the position to 789 shares worth $3.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

Two Sigma Securities first reported a position in VNRX in Q3 2022 and has held it in 11 quarters since. The position peaked at $47K in Q3 2022. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

Two Sigma Securities held 789 shares of VolitionRx Ltd worth $3.19K as of Q1 2026.
Two Sigma Securities bought 59 VolitionRx Ltd shares in Q1 2026, an estimated $282.
VolitionRx Ltd made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1540 holding.
Two Sigma Securities first reported a position in VolitionRx Ltd in Q3 2022 and has held it in 11 quarters since.
Two Sigma Securities's VolitionRx Ltd position peaked at $47K in Q3 2022.
31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.